Moderna wins $176M vaccine contract from U.S. (NASDAQ:MRNA)
hapabapa Moderna (NASDAQ:MRNA) on Tuesday announced a $176M contract from the U.S. government to accelerate the development of messenger-RNA-based vaccines targeting several influenza strains, including the bird flu family of viruses. The company said that the funding channeled through the Biomedical Advanced Research and Development Authority (BARDA) is expected toContinue Reading